LZTS2 and PTEN collaboratively regulate ß-catenin in prostatic tumorigenesis

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Leucine zipper tumor suppressor 2 (LZTS2) is a tumor suppressor gene located at 10q24.3, a region frequently deleted in cancers.
• LZTS2 negatively regulates Wnt signaling by binding to β-catenin.
• PTEN, another tumor suppressor, is also located near LZTS2 and its loss is common in prostate cancer.

Purpose of the Study:

• To investigate the collaborative role of PTEN and LZTS2 in prostate cancer development.
• To elucidate the impact of combined PTEN and LZTS2 loss on Wnt/β-catenin signaling and tumor progression.

Main Methods:

• In vitro studies using prostate cancer cell lines.
• In vivo studies utilizing a novel mouse model with combined Pten and Lzts2 deletion.
• Immunohistochemical analysis of tumor tissues.

Main Results:

• Co-expression of PTEN and LZTS2 enhanced the repression of β-catenin-mediated transcription.
• Mice with combined Pten and Lzts2 deletion exhibited earlier onset and accelerated progression of prostate carcinomas.
• Tumor cells from compound deletion mice showed increased cytoplasmic and nuclear β-catenin levels and higher proliferation rates.

Conclusions:

• Simultaneous deletion of PTEN and LZTS2 significantly contributes to prostate oncogenic transformation.
• The combined loss of PTEN and LZTS2 dysregulates Wnt/β-catenin signaling, promoting prostate tumorigenesis.
• These findings highlight a novel mechanism in prostate cancer development involving the interplay of PTEN, LZTS2, and Wnt signaling.